Swiss federal department contributing public health policy, biosafety infrastructure, and pandemic preparedness expertise to European research consortia.
The Swiss Federal Department of Home Affairs (EDI) is a cabinet-level government body responsible for public health, research policy, and science funding in Switzerland. In H2020, it channels Swiss federal expertise into European research on infectious diseases (both human and animal), climate resilience, and risk governance. The department acts as Switzerland's institutional bridge between national health and research agencies and large EU consortia, contributing regulatory insight, biosafety infrastructure access, and policy coordination rather than bench-level research.
Central to SAPHIR, ZIKAlliance, VetBioNet, HONOURs, COV RESTRIC (coordinated), SCORE, and CARE — spanning zoonotic diseases, veterinary infectiology, and COVID-19 therapeutics.
Participated in ESCAPE, ESCAPE-2, and ESiWACE2, all focused on scalable HPC algorithms for weather and climate prediction.
Gov4Nano focused on risk assessment frameworks, safe-by-design approaches, and governance models for nanotechnology — a departure from their health core.
SINCERE and ICRAD involved international research coordination on climate adaptation and infectious animal diseases respectively.
VetBioNet (BSL3 high-containment facilities), SAPHIR (immune response in farm animals), and ICRAD (infectious animal disease coordination) demonstrate deep veterinary biosafety capabilities.
Early H2020 participation (2015–2018) centered on veterinary infectiology, high-containment biosafety infrastructure, zoonotic disease preparedness, and exascale weather prediction algorithms. From 2018 onward, the focus shifted toward risk governance frameworks, international research coordination, climate services, and — critically — rapid COVID-19 response with substantial funding in CARE and SCORE. This arc shows a department moving from specialized infrastructure provision toward broader governance and emergency response roles.
EDI is pivoting from infrastructure-level contributions toward governance, policy coordination, and rapid-response capabilities — making them a strong partner for future pandemic preparedness and One Health initiatives.
Overwhelmingly a consortium participant (17 of 18 projects), with only one coordinator role — the Marie Curie fellowship COV RESTRIC on coronavirus species barriers. With 377 unique partners across 54 countries, they function as a broadly connected node rather than a project leader, joining large multinational consortia where Swiss federal expertise or infrastructure access is needed. This suggests a reliable, low-friction partner that contributes institutional weight and regulatory credibility without seeking to drive the agenda.
Exceptionally broad network of 377 unique partners spanning 54 countries, reflecting Switzerland's position as a neutral, well-connected research hub. The geographic spread is truly global, not limited to Western European core partners.
As a federal government department (not a university or research institute), EDI brings something most consortium partners cannot: direct connection to Swiss national health policy, regulatory authority, and federal research funding decisions. Their pre-COVID work on coronavirus species barriers (COV RESTRIC, 2017–2019) proved remarkably prescient, and their rapid mobilization into SCORE and CARE demonstrated an ability to pivot institutional resources quickly. For consortium builders, EDI offers a credible government-level partner with genuine biosafety infrastructure access and policy influence.
